170 related articles for article (PubMed ID: 10327046)
1. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system.
Hammer-Wilson MJ; Ghahramanlou M; Berns MW
Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046
[TBL] [Abstract][Full Text] [Related]
2. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B
J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320
[TBL] [Abstract][Full Text] [Related]
3. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer.
Young SW; Woodburn KW; Wright M; Mody TD; Fan Q; Sessler JL; Dow WC; Miller RA
Photochem Photobiol; 1996 Jun; 63(6):892-7. PubMed ID: 8992510
[TBL] [Abstract][Full Text] [Related]
4. Phototherapy of cancer and atheromatous plaque with texaphyrins.
Woodburn KW; Fan Q; Kessel D; Wright M; Mody TD; Hemmi G; Magda D; Sessler JL; Dow WC; Miller RA; Young SW
J Clin Laser Med Surg; 1996 Oct; 14(5):343-8. PubMed ID: 9612202
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers.
Hammer-Wilson MJ; Sun CH; Ghahramanlou M; Berns MW
Lasers Surg Med; 1998; 23(5):274-80. PubMed ID: 9888323
[TBL] [Abstract][Full Text] [Related]
6. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
Korbelik M; Sun J; Posakony JJ
Photochem Photobiol; 2001 Apr; 73(4):403-9. PubMed ID: 11332036
[TBL] [Abstract][Full Text] [Related]
7. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
8. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
9. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
Li LB; Luo RC
Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
Chang CJ; Yu JS; Wei FC
Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
13. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729
[TBL] [Abstract][Full Text] [Related]
14. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin.
Woodburn KW; Fan Q; Kessel D; Luo Y; Young SW
J Invest Dermatol; 1998 May; 110(5):746-51. PubMed ID: 9579539
[TBL] [Abstract][Full Text] [Related]
17. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
18. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model.
Woodburn KW; Fan Q; Miles DR; Kessel D; Luo Y; Young SW
Photochem Photobiol; 1997 Mar; 65(3):410-5. PubMed ID: 9077121
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
